Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122690) titled 'Efficacy and Safety of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Depression: A Randomized, Double- Blind, Placebo-Controlled Study' on April 16.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Anding Hospital, Capital Medical University
Condition:
Depression
Intervention:
Intervention Group:Exosomes administered via nasal drops once daily for 12 consecutive days
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-16
Target Sample Size: Intervention Group:25;Control Group:25;
Countries of Recruitment:
China
To know mor...